Viatris Inc (VTRS) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Viatris reported revenue of $14.30B, down 3.0% from $14.74B the year before. Net income was -$3.51B (a -24.6% net margin), or -$3.00 per diluted share. Gross margin was 35.1% and operating margin was -18.6%. Operating activities generated $2.32B of cash, leaving $1.94B of free cash flow. At fiscal year end, Viatris held $37.19B in total assets against $22.48B in total liabilities, including $1.32B of cash and equivalents.
Open the full interactive Viatris financials → Quarterly statements, key ratios, valuation history and price charts.
Viatris Key Stats
| Share Price | $17.25 |
|---|---|
| Market Cap | $20.07B |
| Revenue YoY Growth | -3.0% |
| 52-Week Range | $9.52 – $18.27 |
| Shares Outstanding | 1.16 billion (basic, 2026 Q2) |
Viatris Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $11.95B | $17.89B | $16.26B | $15.43B | $14.74B | $14.30B |
| Cost of Goods Sold | $8.15B | $12.31B | $9.77B | $8.99B | $9.12B | $9.29B |
| Gross Profit | $3.80B | $5.58B | $6.50B | $6.44B | $5.62B | $5.01B |
| Operating Income | -$210.8M | -$34.0M | $1.61B | $766.2M | $10.1M | -$2.66B |
| Pre-Tax Income | -$721.2M | -$664.4M | $2.81B | $202.9M | -$623.2M | -$3.67B |
| Income Tax | -$51.3M | $604.7M | $734.6M | $148.2M | $11.0M | -$150.1M |
| Net Income | -$669.9M | -$1.27B | $2.08B | $54.7M | -$634.2M | -$3.51B |
| Diluted EPS | -$1.11 | -$1.05 | $1.71 | $0.05 | -$0.53 | -$3.00 |
Viatris Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $3.76B | $3.70B | $3.52B | $3.76B |
| Net Income | -$128.2M | -$340.1M | $176.4M | -$118.8M |
| Diluted EPS | -$0.11 | — | $0.15 | -$0.10 |
Viatris Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $844.4M | $701.2M | $1.26B | $991.9M | $734.8M | $1.32B |
| Current Assets | $12.87B | $10.90B | $10.64B | $12.98B | $9.52B | $9.79B |
| Total Assets | $61.55B | $54.84B | $50.02B | $47.69B | $41.50B | $37.19B |
| Current Liabilities | $10.56B | $9.88B | $6.75B | $7.78B | $5.78B | $7.09B |
| Total Long-Term Debt | $24.74B | $21.59B | $19.27B | $18.13B | $14.05B | $14.41B |
| Total Liabilities | $38.60B | $34.35B | $28.95B | $27.22B | $22.87B | $22.48B |
| Shareholders' Equity | $22.95B | $20.49B | $21.07B | $20.47B | $18.64B | $14.71B |
Viatris Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $1.23B | $3.02B | $2.95B | $2.80B | $2.30B | $2.32B |
| Cash From Investing | -$301.1M | -$117.8M | $1.52B | -$764.1M | $1.80B | -$427.7M |
| Cash From Financing | -$605.7M | -$3.01B | -$3.88B | -$2.30B | -$4.33B | -$1.29B |
| Free Cash Flow | $988.8M | $2.56B | $2.55B | $2.42B | $1.98B | $1.94B |
Figures from Viatris' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Viatris financials page for every line item.
Viatris Company Profile
| Ticker | VTRS |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Canonsburg, Pennsylvania |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001792044 |
Frequently Asked Questions
What was Viatris' revenue in fiscal 2025?
Viatris (VTRS) reported revenue of $14.30B for fiscal 2025.
What is Viatris' annual revenue history?
Viatris' annual revenue by fiscal year: 2020: $11.95B; 2021: $17.89B; 2022: $16.26B; 2023: $15.43B; 2024: $14.74B; 2025: $14.30B.
What was Viatris' net income in fiscal 2025?
Viatris reported net income of -$3.51B for fiscal 2025.
What was Viatris' earnings per share (EPS) in fiscal 2025?
Viatris' diluted EPS was -$3.00 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Viatris generate in fiscal 2025?
Viatris generated $1.94B of free cash flow in fiscal 2025.
What was Viatris' revenue last quarter?
In its most recent reported quarter (2026 Q2), Viatris reported revenue of $3.76B.
How much debt does Viatris have?
Viatris reported $14.41B of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Viatris are outstanding?
Viatris reported a weighted average of 1.16 billion basic shares outstanding in 2026 Q2.
What is Viatris' market cap?
Based on its latest closing price, Viatris (VTRS) has a market capitalization of about $20.07B.
When does Viatris' fiscal year end?
Viatris' fiscal year end, as registered with the SEC, is December 31.
Where is Viatris headquartered?
Viatris lists its business address in Canonsburg, Pennsylvania in its SEC filings.